According to the General side effects of semaglutide include: nausea vomiting diarrhea abdominal pain constipation Semaglutide can also lead to complications in some people, including: pancreatitis diabetic retinopathy low blood sugar acute kidney injury hypersensitivity reaction acute gallbladder disease In rodents, semaglutide has been linked to an increased risk of thyroid C-cell tumors
Here's what most dosing guides miss: cagrilintide isn't a once-daily medication you can take at any arbitrary time
Decreased expression of hepatic low-density lipoprotein receptor-related protein 1 in hypothyroidism: a novel mechanism of atherogenic dyslipidemia in hypothyroidism
Essentially all "semaglutide" used in compounding is manufactured by foreign suppliers in China and can use illicit active pharmaceutical ingredients
This week the pharmacy compounding, weight loss and anti-aging communities have been abuzz from the October 2, 2024 announcement from the FDA and Eli Lilly that they are removing both of the brand name tirzepatide blockbuster drugs, Mounjaro and Zepbound from the FDA drug shortage list
Obesity and its associated medical complications are a major problem in Australia and worldwide